caprotec bioanalytics Announces the Appointment of Funakoshi as Distributor for Its Products on the Japanese Market
The company’s products are based on caprotec’s proprietary Capture Compound Mass Spectrometry (CCMS) technology, a direct way to investigate small molecule-protein interactions resulting in a significant functional reduction of proteome complexity.
“To establish a distribution channel for our products into the Japanese market is of strategic importance to us. We believe that our innovative and high quality research products will serve the Japanese researchers well,” stated Dr. Hubert Köster, CEO of caprotec bioanalytics.
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Mass Spectrometry
Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!
Topic World Mass Spectrometry
Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!